Contact This Organization

Rose Health

Rose Health, founded in 2018, is a HIPAA-compliant, augmented intelligence mental health platform that supports behavioral health management and improves collaborative care interoperability.
Mission/Vision
Our mission is to transform mental healthcare form the status quo . We envision a person-first model that allows everyone to access mental healthcare when they need it, while supporting providers to reduce provider burnout.
Type of Organization
Startup - Newly established businesses, investable
Size of Organization
10-50
Organization Mailing Address

3400 Prospect St NW
Washington DC, DC 20009
United States

Rose Care Navigation
Rose enables both mental health and non-mental health care providers to identify patients with behavioural health issues, recognize and address risk, and obtain reimbursement for their care through Behavioural Health CPT codes. Rose's concierge care service is then available for at-risk patients, providing one-to-one coaching, resource matching, and crisis counselling. For large health systems and Accountable Care Organizations, Rose provides population health metrics and enables early recognition of mental health decompensation, thereby reducing costs associated with emergency room visits and hospitalizations. For patients, Rose’s mobile app provides guided care journeys, customized to a patient’s needs through Rose’s patented AI and NLP algorithms and supported by clinical oversight from their provider.
Category of Innovation
Digital Health - A digital health solution is a technology-based solution whose user is caring for or providing care for themselves (think of a personal app) or another individual (such as a doctor using a tool to help their patient)
Intended End User
Patient - Individuals who receive health care
Provider - Individuals or organizations responsible for providing care to patients (e.g. doctors, nurses, hospital/clinic administrators, etc.)
Impactful Innovation Stage (Click Here for Details)
Adoption
Problem (i.e. barrier, issue, complication, etc.) being solved for the end user
One in five people in the US (approx. 47 million) suffer from a mental health disorder, a number increasing due to COVID-19. Even before the pandemic, there was an estimated deficit of 100,000 mental health clinicians. As a result, the burden of mental health treatment increasingly falls on primary care providers (PCPs). Estimates suggest 80% of mental health care is handled by PCPs, making them the first and sometimes only line of defense for patients. These providers do their best, but with only an average of 5 minutes to hear about a patient’s experiences, PCPs are often unable to do more than prescribe medication. In fact, less than 10% of PCPs are satisfied with the mental health services they offer their patients. This has left a gap where over-burdened PCPs struggle to provide the mental health treatment and resources patients need, while keeping patients engaged and avoiding decompensation, ER visits, and loss of life.
Idea/solution to the problem, if applicable
Rose is a reimbursable mental health platform with an app for patients that delivers assessments and mental health resources, and a web-based clinician dashboard that allows for remote monitoring, triaging, and intervention. Distilled app data populates the dashboard in real-time and can be monitored by nurses or MAs, with clinical oversight. Rose takes a machine learning approach to mental health, with proprietary algorithms that allow us to identify patients at risk for mental health decompensation. From a provider’s EHR, they can invite their patient population to join Rose. As a patient uses the app, Rose’s algorithms process thousands of data points to generate a “Rose score” that provides an objective, multi-dimensional picture of that patient’s mental health. If a patient is a low risk, they continue to use Rose’s self-help tools, and will be flagged should they deteriorate. For those who are high risk, Rose’s care navigation team can coach the patient, identify resources, and match them with a long-term therapist. Rose allows providers to improve the overall behavioral health outcomes of their patient panel while generating at base $66,000 per year in ancillary revenue through behavioral health reimbursement structures.
Level of adoption (i.e. list of customers/users, testimonials, etc.), if applicable
Rose’s customers are clinicians in independent practices and health systems. Rose is currently being used by primary care providers, pain specialists, and psychiatrists. Additionally, Rose is used by these clinician’s nurses, medical assistants, and office staff to manage patient loads and fully integrate mental healthcare into the practice. Currently, Rose has about 50 small-to-medium sized clinics using Rose, as well as pilots with Intermountain Healthcare, the Visiting Nurses Services of New York, Shepherd Pratt Hospital, Dublin Medical, Coastal Medical, and Oscner Health.
Impact (i.e. measurable outcomes), if applicable
From a financial impact perspective, a single PCP can net an additional $66,000 per year just by offering Rose to his or her patients. PCPs have successfuly been reimbursed for using Rose under the CPT code 99484 for behavioural health integration, as well as various CPT codes for Remote Patient Monitoring. Beyond providing ancillary revenue to primary care physicians and psychiatrists, Rose empoys data-driven care navigation, lowering costs for both patients and providers. By improving diagnosis and personalizing health metrics, the right care is given to the right patients at the right time. In Rose’s published two-arm clinical study, 73% of participants showed statistically significant improvement in their PHQ-9/GAD-7 scores within 4 weeks of use. At baseline, providers see the following: increased screening for behavioural health conditions (especially for depression), increased completion of follow-up clinical assessments, and improved PHQ-9 and GAD-7 by 3-4 points over 4 weeks. Through increased access to providers and active and digital biomarkers that augment provider intelligence, Rose could allow for early detection of decompensation, reduce ER visits and hospitalizations, increase patient adherence, and improve rates of depression remission.
Funding Stage
Grant funded
Seed
List of Funding Sources (if applicable)
The Visiting Nurse Service of New York, Old Line Capital, and JRSD Ventures.
Certifications?
Yes
HIPPA certification
Has your company attested to any codes of conduct?
Yes